BioSpace News Archive

Drug Development

Viking Therapeutics Announces Positive Top-Line Results from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH)

Viking Therapeutics, Inc. today announced positive top-line results from its Phase 2b clinical trial of VK2809, the company’s novel liver-selective thyroid hormone receptor beta agonist, in patients with biopsy-confirmed non-alcoholic steatohepatitis (NASH).

May 16, 2023
·
11 min read
Business

AlloVir Announces Appointment of Cintia Piccina, PharmD, MBA, as Chief Commercial Officer

AlloVir today announced the appointment of Cintia Piccina, PharmD, MBA, as the company’s Chief Commercial Officer, effective June 12, 2023.

May 16, 2023
·
5 min read
Business

Verastem Oncology Appoints Karin Tollefson, PhD, to Board of Directors

Verastem Oncology today announced the appointment of Karin Tollefson to its Board of Directors, effective May 15, 2023.

May 16, 2023
·
7 min read
FDA

Bayer Receives U.S. FDA Fast Track Designation for asundexian Atrial Fibrillation Program

Bayer today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for its investigational drug asundexian (BAY2433334) as a potential treatment to prevent stroke and systemic embolism in people with atrial fibrillation (AF).

May 16, 2023
·
6 min read
Lone Star Bio

EPI’s Pulvinar Neuro is Awarded $3 Million NIH Grant for Transcranial Stimulation Research

Pulvinar Neuro was awarded a grant from the National Institutes of Health (NIH) to further its research in transcranial stimulation (TCS) as a potential treatment for psychiatric disorders.

May 16, 2023
·
2 min read
Business

SoftWave Tissue Regeneration Technologies Receives Innovative Technology Contract From Vizient for DermaGold

SoftWave Tissue Regeneration Technologies announced its DermaGold an advanced wound care technology, has received an Innovative Technology contract from Vizient, Inc.

May 16, 2023
·
3 min read
Bio NC

New Study Confirms Consistent Risk of Myelosuppression Across All Patients Receiving Chemotherapy for Small Cell Lung Cancer

G1 Therapeutics, Inc., a commercial-stage oncology company, described recently presented real-world data that confirm a consistent risk of myelosuppressive events across patients with small cell lung cancer being treated with chemotherapy.

May 16, 2023
·
6 min read
Alkermes Highlights Data From Psychiatry Portfolio at Spring 2023 Scientific Conferences

Alkermes plc announced the presentation of research related to its psychiatry portfolio—which includes LYBALVI® and ARISTADA® —at four scientific conferences this spring.

May 16, 2023
·
20 min read
Biotech Beach

Boundless Bio Announces $100 Million Oversubscribed Series C Financing co-led by Leaps by Bayer and RA Capital Management to Advance the First ecDNA-Directed Therapies (ecDTx) for Patients with Oncogene Amplified Cancer

Boundless Bio today announced the closing of a $100 million Series C financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and RA Capital Management, with participation from additional new investors, Sectoral Asset Management and Piper Heartland Healthcare Capital.

May 16, 2023
·
5 min read
Lone Star Bio

Coya Therapeutics’ COYA 301 Increased Treg Function and Halted Cognitive Decline in an Open Label Study in Patients with Alzheimer’s Disease

Coya Therapeutics, Inc. today reported results from an open-label proof-of-concept clinical study for COYA 301 in patients with AD.

May 16, 2023
·
10 min read